EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Vitamin B6 challenge as a tool for detecting ALPL mutations and diagnosing hypophosphatasia

Sofía Alvarez, Amelia Ocampo, Patricia C Caso, Alvaro Del Real, Nuria Puente, Ana I Vega, Leyre Riancho-Zarrabeitia, María T García-Unzueta, José A Riancho

Osteoporosis International · 2025-09 · 36 (9) · 1743-1747

DOI: 10.1007/s00198-025-07595-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Osteoporosis International, online erschienen am 28.06.2025. Verfasst von Sofía Alvarez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Medicina Interna, Hospital U.M. Valdecilla, Av Valdecilla sn, 39008, Santander, Spain. Hauptthemen laut MEDLINE: Hypophosphatasia, Alkaline Phosphatase, Mutation, Vitamin B 6. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Universidad de Cantabria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low serum alkaline phosphatase is the biochemical hallmark of hypophosphatasia. However, it is a non-specific finding. Here we show that a 2-day vitamin B6 challenge is useful to identify carriers of ALPL gene mutations among patients with low serum alkaline phosphatase, with specificity and sensitivity over 90%. PURPOSE: Hypophosphatasia (HPP) is a disorder characterized by deficient activity of the tissue non-specific alkaline phosphatase (ALP) isoenzyme, due to pathogenic variants of the ALPL gene. The biochemical hallmark of HPP is the reduced ALP activity in serum. Pyridoxal 5'-phosphate (PLP), the major circulating form of vitamin B6, is a substrate of ALP. Thus, high PLP levels are commonly used as a diagnostic marker of HPP. This study aimed to assess the diagnostic utility of vitamin B6 supplementation for identifying patients with ALPL variants. PATIENTS AND METHODS: We measured PLP in control subjects and patients with low serum ALP, with or without ALPL mutations, at baseline and after a 2-day or 6-day vitamin B6 supplementation (20 mg per day of pyridoxine hydrochloride). RESULTS: Although mutation carriers tended to have higher PLP values, up to 33% had baseline levels within the normal range. The vitamin B6 challenge, particularly with the 2-day protocol, improved the diagnostic performance. After 2-day supplementation, all carriers had levels above 500 nmol/l (sensitivity 100%; CI 95-100), whereas only 1 non-carrier surpassed that threshold (specificity 96%; CI 85-100). CONCLUSION: A 2-day vitamin B6 supplementation test may be useful for identifying carriers of ALPL mutations among individuals with unexplained low serum ALP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypophosphatasiaAlkaline PhosphataseMutationVitamin B 6HumansFemaleMalePyridoxal PhosphateAdultMiddle AgedYoung AdultBiomarkersCase-Control StudiesAdolescentAgedSensitivity and Specificity

Stichwörter der Autor:innen

Alkaline phosphataseDiagnosisHypophosphatasiaPyridoxal phosphateVitamin B6

Substanzen

Alkaline PhosphataseALPL protein, humanPyridoxal PhosphateVitamin B 6Biomarkers

Autor:innen und Institutionen

  • Servicio de Medicina Interna, Hospital U.M. Valdecilla, Av Valdecilla sn, 39008, Santander, Spain.
  • Departamento de Medicina y Psiquiatría, Universidad de Cantabria, Santander, Spain.
  • Servicio de Genética, Hospital U.M. Valdecilla, Santander, Spain.
  • Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Servicio de Reumatología, Hospital Sierrallana, Torrelavega, Spain.

Förderung

  • Universidad de Cantabria

Zitieren

APA

Alvarez, S., Ocampo, A., Caso, P. C., Del Real, A., Puente, N., Vega, A. I., Riancho-Zarrabeitia, L., García-Unzueta, M. T., & Riancho, J. A. (2025). Vitamin B6 challenge as a tool for detecting ALPL mutations and diagnosing hypophosphatasia. Osteoporosis International, 36(9), 1743-1747. https://doi.org/10.1007/s00198-025-07595-x

Vancouver

Alvarez S, Ocampo A, Caso PC, Del Real A, Puente N, Vega AI, et al. Vitamin B6 challenge as a tool for detecting ALPL mutations and diagnosing hypophosphatasia. Osteoporosis International. 2025;36(9):1743-1747. doi:10.1007/s00198-025-07595-x

BibTeX
@article{Alvarez2025,
  author = {Alvarez, Sofía and Ocampo, Amelia and Caso, Patricia C and Del Real, Alvaro and Puente, Nuria and Vega, Ana I and Riancho-Zarrabeitia, Leyre and García-Unzueta, María T and Riancho, José A},
  title = {Vitamin B6 challenge as a tool for detecting ALPL mutations and diagnosing hypophosphatasia},
  journal = {Osteoporosis International},
  year = {2025},
  volume = {36},
  number = {9},
  pages = {1743--1747},
  doi = {10.1007/s00198-025-07595-x}
}
Kostenlos starten →